Effect of aripiprazole once-monthly 400mg (AOM400) on hospitalisation prevention and use of healthcare resources in schizophrenia patients, a study based on real clinical practice on schizophrenia: AMBITION Study

被引：0
|
作者：
Sanchez-Gistau, V. [1 ]
J. Moreno, M. [2 ]
Gomez-Lus, S. [2 ]
Sicras Mainar, A. [3 ]
Crespo-Facorro, B. [4 ]
机构：
[1] Univ Rovira & Virgili, Hosp Univ Inst Pere Mata, Early Intervent Psychosis Serv, IISPV, Reus, Spain
[2] Otsuka Lundbeck Alliance, Med Dept, Barcelona, Spain
[3] Atrys Hlth SA, Madrid, Spain
[4] Univ Seville, Univ Hosp Virgen Del Rocio, Sch Med, Dept Psychiat,CSIC,IBiS CIBERSAM, Seville, Spain
来源：
EUROPEAN PSYCHIATRY | 2023年 / 66卷
关键词：
D O I：
10.1192/j.eurpsy.2023.1052
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0765
引用
收藏
页码：S494 / S494
页数：1
相关论文
共 18 条
  • [1] Effect of aripiprazole once-monthly 400mg (AOM400) on hospitalisation prevention and use of healthcare resources in schizophrenia patients, a study based on real clinical practice on schizophrenia: AMBITION Study
    Sanchez-Gistau, V.
    Moreno, M. J.
    Gomez-Lus, S.
    Mainar, A. Sicras
    Crespo-Facorro, B.
    EUROPEAN PSYCHIATRY, 2023, 66 : S494 - S494
  • [2] Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
    Yan, Tingjian
    Greene, Mallik
    Chang, Eunice
    Hartry, Ann
    Touya, Maelys
    Broder, Michael S.
    ADVANCES IN THERAPY, 2018, 35 (10) : 1612 - 1625
  • [3] Healthcare resource use and costs reduction with aripiprazole once-monthly in schizophrenia: AMBITION, a real-world study
    Sanchez-Gistau, Vanessa
    Moreno, Maria Jose
    Gomez-Lus, Susana
    Sicras-Mainar, Antoni
    Crespo-Facorro, Benedicto
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [4] Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
    Tingjian Yan
    Mallik Greene
    Eunice Chang
    Ann Hartry
    Maëlys Touya
    Michael S. Broder
    Advances in Therapy, 2018, 35 : 1612 - 1625
  • [5] Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: A 52-week open-label study
    Peters-Strickland T.
    Baker R.A.
    McQuade R.D.
    Jin N.
    Eramo A.
    Perry P.
    Johnson B.R.
    Duca A.
    Sanchez R.
    npj Schizophrenia, 1 (1):
  • [6] Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)
    Oloruntoba Oluboka
    Guerline Clerzius
    Wolfgang Janetzky
    Daniel Schöttle
    François Therrien
    Klaus Wiedemann
    Marc-André Roy
    BMC Psychiatry, 23
  • [7] Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)
    Oluboka, Oloruntoba
    Clerzius, Guerline
    Janetzky, Wolfgang
    Schoettle, Daniel
    Therrien, Francois
    Wiedemann, Klaus
    Roy, Marc-Andre
    BMC PSYCHIATRY, 2023, 23 (01)
  • [8] Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study
    Olivares, Jose Manuel
    Gonzalez-Pinto, Ana
    Paramo, Mario
    EUROPEAN PSYCHIATRY, 2021, 64 (01)
  • [9] Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
    Daniel Schöttle
    Wolfgang Janetzky
    Daniel Luedecke
    Elmar Beck
    Christoph U. Correll
    Klaus Wiedemann
    BMC Psychiatry, 18
  • [10] Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
    Schoettle, Daniel
    Janetzky, Wolfgang
    Luedecke, Daniel
    Beck, Elmar
    Correll, Christoph U.
    Wiedemann, Klaus
    BMC PSYCHIATRY, 2018, 18
12